» Authors » Jian-Fei Tu

Jian-Fei Tu

Explore the profile of Jian-Fei Tu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 162
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Q, Ge N, Li Y, Huang M, Li W, Lu D, et al.
Int J Surg . 2024 Sep; 111(1):706-717. PMID: 39311927
Background And Aims: Self-expandable metallic stents (SEMSs) have been recommended for patients with unresectable malignant biliary obstruction, while radiation-emitting metallic stents (REMSs) loaded with 125 I seeds have recently been...
2.
Zhu H, Li X, Ji J, Huang M, Shao G, Lu J, et al.
Eur Radiol . 2022 Jul; 32(11):7335-7343. PMID: 35776182
Objectives: To investigate the efficacy and safety of dicycloplatin as chemotherapeutic regimen in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Methods: In this randomized, open-label, phase II trial, patients...
3.
Liu W, Tu J, Ying X, Chen Z, Wang Y
BMJ Open . 2022 Apr; 12(4):e049789. PMID: 35414539
Objectives: The study was designed to clarify the difference between extrahepatic cholangiocarcinoma (ECC) and intrahepatic cholangiocarcinoma (ICC) in postoperative cancer-specific death. Design: Patients diagnosed with ECC and ICC after surgery,...
4.
Tu J, Ding Y, Chen L, Ying X, Zhang D, Wu F, et al.
Sci Rep . 2017 Jun; 7(1):3689. PMID: 28623296
This study evaluated if iodine-125 brachytherapy prophylaxis after radiofrequency ablation (RFA) prolongs time to recurrence (TTR) and overall survival (OS) of patients in high risk of locoregional hepatocellular carcinoma (HCC)...
5.
Wang Z, Fan X, Xu M, Chen M, Zhao Z, Zhou J, et al.
Tumour Biol . 2017 May; 39(5):1010428317701656. PMID: 28475013
Our study aims to evaluate the efficacy of transcatheter arterial chemoembolization in the treatment of patients with liver metastasis using integrated F-fluorodeoxyglucose positron emission tomography/computed tomography. A total of 97...
6.
Zhao Z, Fan X, Song J, Xu M, Chen M, Tu J, et al.
J Cell Mol Med . 2017 Apr; 21(9):1989-1999. PMID: 28429395
To investigate the effects of lentiviral vector-mediated shRNA suppressing CXCR7 on tumour invasion and metastasis in hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE). HCCLM3 cell lines were cultured and...
7.
Tu J, Ding Y, Ying X, Wu F, Zhou X, Zhang D, et al.
Sci Rep . 2016 Oct; 6:35056. PMID: 27725696
Hepatocellular carcinoma (HCC) is a common malignant tumour, especially in Asia. Its prognosis is poor, and there are limited methods for predicting patient survival. This study was carried out to...
8.
Ji J, Xu M, Song J, Zhao Z, Chen M, Chen W, et al.
Onco Targets Ther . 2016 Aug; 9:4357-67. PMID: 27499630
MicroRNA-126 (miR-126) has been found to promote angiogenesis, but the underlying mechanisms are still unclear. So, we conducted this study to explore the effect of miR-126 expression on angiogenesis in...
9.
Qian L, Tu J, Ding Y, Pang J, Che X, Zou H, et al.
Medicine (Baltimore) . 2016 Jul; 95(29):e4293. PMID: 27442673
The functional crosstalk between nonalcoholic fatty liver disease (NAFLD) and hypertension has been reported by some literatures; however, in nonhypertensive individuals, there is no article describes the characteristic of NAFLD....
10.
Tu J, Pan H, Ying X, Lou J, Ji J, Zou H
Medicine (Baltimore) . 2016 Apr; 95(13):e3220. PMID: 27043690
IL-17 and IL-17-producing cells have been found in many types of human cancers and murine models. However, the source of tumor-infiltrating IL-17 and IL-17-producing cells in HCC and the prognostic...